These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 1352942)
21. Immunohistochemical evaluation of neoplasms in bone marrow biopsies using monoclonal antibodies reactive in paraffin-embedded tissue. Kubic VL; Brunning RD Mod Pathol; 1989 Nov; 2(6):618-29. PubMed ID: 2587569 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan. Funamoto Y; Nagai M; Haba R; Ishikawa M; Kishida F; Kohno K; Matsunaga T; Kushida Y; Kobayashi S Diagn Cytopathol; 2005 Jul; 33(1):20-5. PubMed ID: 15945083 [TBL] [Abstract][Full Text] [Related]
23. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping of hematologic neoplasms in paraffin-embedded tissue sections. Davey FR; Elghetany MT; Kurec AS Am J Clin Pathol; 1990 Apr; 93(4 Suppl 1):S17-26. PubMed ID: 2180277 [TBL] [Abstract][Full Text] [Related]
25. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210 [TBL] [Abstract][Full Text] [Related]
26. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. Herbst H; Raff T; Stein H J Pathol; 1996 May; 179(1):54-9. PubMed ID: 8691346 [TBL] [Abstract][Full Text] [Related]
27. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082 [TBL] [Abstract][Full Text] [Related]
28. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Kadin ME; Muramoto L; Said J Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547 [TBL] [Abstract][Full Text] [Related]
29. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases. Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110 [TBL] [Abstract][Full Text] [Related]
30. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508 [TBL] [Abstract][Full Text] [Related]
31. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Gonzalez CL; Medeiros LJ; Jaffe ES Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139 [TBL] [Abstract][Full Text] [Related]
32. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections. West KP; Warford A; Fray L; Allen M; Campbell AC; Lauder I J Pathol; 1986 Oct; 150(2):89-101. PubMed ID: 3540244 [TBL] [Abstract][Full Text] [Related]
33. [The immunological characterization of 63 cases of Hodgkin's disease with a panel of 8 antibodies]. Oliva-Aldamiz H; Echezarreta G; Aguilera B; Cuevas E; Barat A; Sarasa JL; Renedo G; Rivas F; Forteza J; Sánchez-Fayos MP Rev Clin Esp; 1992 Mar; 190(5):229-37. PubMed ID: 1374567 [TBL] [Abstract][Full Text] [Related]
34. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Pinkus GS; Thomas P; Said JW Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932 [TBL] [Abstract][Full Text] [Related]
35. [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases]. Voigt JJ; Vinel JP; Caverivière P; Pradère B; Chittal S; al Saati T; Calès P; Delsol G Gastroenterol Clin Biol; 1989 Apr; 13(4):343-52. PubMed ID: 2661293 [TBL] [Abstract][Full Text] [Related]
36. The clinical relevance of L26, a B-cell-specific antibody, in Hodgkin's disease. Molot RJ; Mendenhall NP; Barré DM; Braylan RC Am J Clin Oncol; 1994 Jun; 17(3):185-8. PubMed ID: 7514847 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections. Wieczorek R; Buck D; Bindl J; Knowles DM Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Carbone A; Gloghini A; Volpe R Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287 [TBL] [Abstract][Full Text] [Related]
39. Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease. A clinical, histologic, and immunophenotypic study of 14 cases. Zarate-Osorno A; Medeiros LJ; Longo DL; Jaffe ES Am J Surg Pathol; 1992 Sep; 16(9):885-95. PubMed ID: 1415907 [TBL] [Abstract][Full Text] [Related]
40. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Amini RM; Enblad G; Sundström C; Glimelius B Int J Cancer; 1997 May; 71(4):510-6. PubMed ID: 9178801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]